LoginRegister
    Granules India gets EIR from USFDA for Paracetamol, Metformin API manufacturing plantGranules India gets EIR from USFDA for Paracetamol, Metformin API manufacturing plant
    Medical Devices Sector: CII seeks Government to bring trade margin rationalisationMedical Devices Sector: CII seeks Government to bring trade margin rationalisation
    Everstone-backed Everlife names Raman Gandotra as new CEOEverstone-backed Everlife names Raman Gandotra as new CEO
    One Drug, Multiple Manufacturing Facilities: CDSCO approves manufacturing of new drug in additional sitesOne Drug, Multiple Manufacturing Facilities: CDSCO approves manufacturing of new drug in additional...
    UK drug regulator MHRA reinstates full GMP status to Indoco Goa Plant IUK drug regulator MHRA reinstates full GMP status to Indoco Goa Plant I
    Lupin: FIRST to win Canadian approval for generic version of Inderal-LA capsulesLupin: FIRST to win Canadian approval for generic version of Inderal-LA capsules
    Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20
    Bayer, Monsanto India mega-merger worth USD 63 billion gets clearance from NCLTBayer, Monsanto India mega-merger worth USD 63 billion gets clearance from NCLT
    Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulatorsCarcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators
    Biocon inks license, supply pact with CMS for 3 generic formulationsBiocon inks license, supply pact with CMS for 3 generic formulations
    Dr Reddys gets EIR from USFDA for manufacturing plants at DuvvadaDr Reddys gets EIR from USFDA for manufacturing plants at Duvvada
    First AI-powered X-ray System: GE Healthcare bags USFDA approvalFirst AI-powered X-ray System: GE Healthcare bags USFDA approval
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X